Chaim Lebovits Brainstorm Cell Therapeutics Inc. (BCLI) insider trading activity

Chaim Lebovits is President & CEO of BRAINSTORM CELL THERAPEUTICS INC.. Currently has a direct ownership of 80,960 shares of BCLI, which is worth approximately $138,441. The most recent transaction as insider was on Oct 01, 2024, when has been sold 1,836 shares (Common Stock) at a price of $3.43 per share, resulting in proceeds of $6,297. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 81K

93.05% 3M change

72.4% 12M change

Total Value Held $138,441

Chaim Lebovits Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 01 2024	BUY Open market or private purchase	$6,297 $3.43 p/Share	1,836 Added 2.22%	80,960 Common Stock
Sep 30 2024	BUY Open market or private purchase	$5,060 $0.23 p/Share	22,000 Added 1.82%	1,186,865 Common Stock
May 28 2024	BUY Grant, award, or other acquisition	$7,800 $0.52 p/Share	15,000 Added 1.27%	1,164,865 Common Stock
May 22 2024	BUY Grant, award, or other acquisition	$16,000 $0.64 p/Share	25,000 Added 2.13%	1,149,865 Common Stock
May 21 2024	BUY Grant, award, or other acquisition	$14,499 $0.58 p/Share	25,000 Added 2.17%	1,124,865 Common Stock
May 13 2024	BUY Grant, award, or other acquisition	$4,900 $0.49 p/Share	10,000 Added 0.9%	1,099,865 Common Stock
May 11 2024	BUY Grant, award, or other acquisition	$4,700 $0.47 p/Share	10,000 Added 0.91%	1,089,865 Common Stock
May 10 2024	BUY Grant, award, or other acquisition	$9,200 $0.46 p/Share	20,000 Added 1.82%	1,079,865 Common Stock
May 07 2024	BUY Grant, award, or other acquisition	$24,531 $0.37 p/Share	66,300 Added 5.89%	1,059,865 Common Stock
May 06 2024	BUY Grant, award, or other acquisition	$51,300 $0.38 p/Share	135,000 Added 11.96%	993,565 Common Stock
Apr 19 2024	BUY Grant, award, or other acquisition	$7,800 $0.52 p/Share	15,000 Added 1.72%	858,565 Common Stock
Apr 18 2024	BUY Grant, award, or other acquisition	$60,988 $0.53 p/Share	115,072 Added 12.0%	843,565 Common Stock
Apr 17 2024	BUY Grant, award, or other acquisition	$71,500 $0.55 p/Share	130,000 Added 15.14%	728,493 Common Stock
Mar 11 2024	BUY Grant, award, or other acquisition	-	305,198 Added 33.77%	598,493 Common Stock
Aug 02 2023	BUY Grant, award, or other acquisition	-	31,185 Added 9.61%	293,295 Common Stock
Apr 20 2023	BUY Grant, award, or other acquisition	-	75,000 Added 22.25%	262,110 Common Stock
Sep 18 2022	BUY Grant, award, or other acquisition	-	31,185 Added 14.29%	187,110 Common Stock
Dec 10 2021	BUY Grant, award, or other acquisition	-	31,185 Added 16.67%	155,925 Common Stock

Chaim Lebovits

President & CEO

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCLI shares.

Notify only if

Value

Insider Trading

Get notified when an Brainstorm Cell Therapeutics Inc. insider buys or sells BCLI shares.

Notify only if

Operation

Value

Type

News

Receive news related to BRAINSTORM CELL THERAPEUTICS INC.

Track Activities on BCLI

Account